Results 281 to 290 of about 2,051,186 (321)
Some of the next articles are maybe not open access.
The Lancet, 2012
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended. Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by
Weirong, Ren +4 more
+14 more sources
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended. Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by
Weirong, Ren +4 more
+14 more sources
Biomarkers for immunotherapy of hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2023Tim F Greten +2 more
exaly +2 more sources
Evolving therapeutic landscape of advanced hepatocellular carcinoma
Nature Reviews Gastroenterology and Hepatology, 2022Linmeng Zhang +2 more
exaly +2 more sources
Current Opinion in Gastroenterology, 2003
The number of papers published in the topic of hepatocellular carcinoma (HCC) increased remarkably from last year. The prevalence of chronic hepatitis C infection has increased the incidence of HCC. However, studies confirm that obesity and nonalcoholic fatty liver disease are important factors for the development of HCC in the United States.
Josep M, Llovet +2 more
+9 more sources
The number of papers published in the topic of hepatocellular carcinoma (HCC) increased remarkably from last year. The prevalence of chronic hepatitis C infection has increased the incidence of HCC. However, studies confirm that obesity and nonalcoholic fatty liver disease are important factors for the development of HCC in the United States.
Josep M, Llovet +2 more
+9 more sources
Current Opinion in Gastroenterology, 2002
The number of papers published regarding hepatocellular carcinoma increased remarkably over the previous year. The 1-year survival for hepatocellular carcinoma has only improved slightly over the past 20 years, while the overall survival has remained unchanged.
Mary Ann, Huang, Jorge A, Marrero
openaire +4 more sources
The number of papers published regarding hepatocellular carcinoma increased remarkably over the previous year. The 1-year survival for hepatocellular carcinoma has only improved slightly over the past 20 years, while the overall survival has remained unchanged.
Mary Ann, Huang, Jorge A, Marrero
openaire +4 more sources
Current Opinion in Gastroenterology, 1997
Hepatitis C infection is associated with the development of hepatocellular carcinoma, and progress has been made in a number of areas. Transgenic mice lines expressing the hepatitis C core protein develop hepatic steatosis, adenomas, and hepatocellular carcinomas, with no significant hepatitis or fibrosis.
Özsarlak, Ö. +4 more
openaire +11 more sources
Hepatitis C infection is associated with the development of hepatocellular carcinoma, and progress has been made in a number of areas. Transgenic mice lines expressing the hepatitis C core protein develop hepatic steatosis, adenomas, and hepatocellular carcinomas, with no significant hepatitis or fibrosis.
Özsarlak, Ö. +4 more
openaire +11 more sources
Management of Hepatocellular Carcinoma: A Review.
JAMA Surgery, 2023Importance Hepatocellular carcinoma (HCC) is the sixth most common malignancy and fourth leading cause of cancer-related death worldwide. Recent advances in systemic and locoregional therapies have led to changes in many guidelines regarding systemic ...
Zachary J. Brown +6 more
semanticscholar +1 more source
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
Journal of Hepatology, 2018Summary Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem.
P. Galle +7 more
semanticscholar +1 more source
Surgical Oncology Clinics of North America
An update on the management of Hepatocellular carcinoma (HCC) is provided in the present article for those interested in the UEMS/EBSQ exam in Surgical Oncology. The most recent publications in HCC, including surveillance, guidelines, and indications for liver resection, liver transplantation, and locoregional or systemic therapies, are summarised. The
Adam C, Yopp, Maria B, Majella Doyle
+7 more sources
An update on the management of Hepatocellular carcinoma (HCC) is provided in the present article for those interested in the UEMS/EBSQ exam in Surgical Oncology. The most recent publications in HCC, including surveillance, guidelines, and indications for liver resection, liver transplantation, and locoregional or systemic therapies, are summarised. The
Adam C, Yopp, Maria B, Majella Doyle
+7 more sources